Inhibition of RNA transcription: a biochemical mechanism of action against chronic lymphocytic leukemia cells by fludarabine

[1]  Xiaodong Wang,et al.  Nucleotide Requirements for the in Vitro Activation of the Apoptosis Protein-activating Factor-1-mediated Caspase Pathway* , 2000, The Journal of Biological Chemistry.

[2]  John Calvin Reed,et al.  Bryostatin and CD40‐ligand enhance apoptosis resistance and induce expression of cell survival genes in B‐cell chronic lymphocytic leukaemia , 1999, British journal of haematology.

[3]  E J Freireich,et al.  Long-term follow-up of patients with chronic lymphocytic leukemia (CLL) receiving fludarabine regimens as initial therapy. , 1998, Blood.

[4]  John Calvin Reed.  Molecular biology of chronic lymphocytic leukemia. , 1998, Seminars in oncology.

[5]  W. Plunkett,et al.  Biochemical characterization of the protein activity responsible for high molecular weight DNA fragmentation during drug-induced apoptosis. , 1997, Cancer research.

[6]  T. Kipps.  Chronic lymphocytic leukemia , 1997, Current opinion in hematology.

[7]  H. Iwasaki,et al.  Differential incorporation of ara-C, gemcitabine, and fludarabine into replicating and repairing DNA in proliferating human leukemia cells. , 1997, Blood.

[8]  A. Markham,et al.  Fludarabine , 2012, Drugs.

[9]  W. Plunkett,et al.  Fludarabine triphosphate inhibits nucleotide excision repair of cisplatin-induced DNA adducts in vitro. , 1997, Cancer research.

[10]  B. Cheson,et al.  Treatment of refractory chronic lymphocytic leukemia with fludarabine phosphate via the group C protocol mechanism of the National Cancer Institute: five-year follow-up report. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[11]  E. Estey,et al.  Clinical experience with fludarabine in hemato-oncology. , 1996, Hematology and cell therapy.

[12]  W. Plunkett,et al.  Fludarabine-mediated inhibition of nucleotide excision repair induces apoptosis in quiescent human lymphocytes. , 1996, Clinical cancer research : an official journal of the American Association for Cancer Research.

[13]  John Calvin Reed,et al.  Drug-induced apoptosis in B-cell chronic lymphocytic leukemia: relationship between p53 gene mutation and bcl-2/bax proteins in drug resistance. , 1996, Oncogene.

[14]  P. Hentosh,et al.  In vitro transcription of DNA containing 2-chloro-2'-deoxyadenosine monophosphate. , 1995, Molecular pharmacology.

[15]  W. Plunkett,et al.  High molecular weight DNA fragmentation: a critical event in nucleoside analogue-induced apoptosis in leukemia cells. , 1995, Clinical cancer research : an official journal of the American Association for Cancer Research.

[16]  W. Plunkett,et al.  Arabinosyl-2-fluoroadenine augments cisplatin cytotoxicity and inhibits cisplatin-DNA cross-link repair. , 1995, Molecular pharmacology.

[17]  W. Plunkett,et al.  Functional Compartmentation of dCTP Pools , 1995, The Journal of Biological Chemistry.

[18]  J. Cherrington,et al.  Kinetic analysis of the interaction between the diphosphate of (S)-1-(3-hydroxy-2-phosphonylemthoxypropyl)cytosine, ddCTP, AZTTP, and FIAUTP with human DNA polymerases β and γ , 1994 .

[19]  E. Newcomb,et al.  Chemosensitivity of lymphocytes from patients with B-cell chronic lymphocytic leukemia to chlorambucil, fludarabine, and camptothecin analogs. , 1994, Blood.

[20]  G. Faguet,et al.  Chronic lymphocytic leukemia: an updated review. , 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[21]  A. Saven,et al.  2-Chlorodeoxyadenosine: A Newer Purine Analog Active in the Treatment of Indolent Lymphoid Malignancies , 1994, Annals of Internal Medicine.

[22]  C. Catapano,et al.  Primer RNA chain termination induced by 9-beta-D-arabinofuranosyl-2-fluoroadenine 5'-triphosphate. A mechanism of DNA synthesis inhibition. , 1993, The Journal of biological chemistry.

[23]  F. Becker,et al.  Dual mode of inhibition of purified DNA ligase I from human cells by 9-beta-D-arabinofuranosyl-2-fluoroadenine triphosphate. , 1992, The Journal of biological chemistry.

[24]  L. Hertel,et al.  Action of 2',2'-difluorodeoxycytidine on DNA synthesis. , 1991, Cancer research.

[25]  J. H. Pope,et al.  Effects of cycloheximide on B-chronic lymphocytic leukaemic and normal lymphocytes in vitro: induction of apoptosis. , 1991, British Journal of Cancer.

[26]  W. Plunkett,et al.  Action of 9-beta-D-arabinofuranosyl-2-fluoroadenine on RNA metabolism. , 1991, Molecular pharmacology.

[27]  K. Foon,et al.  Chronic lymphocytic leukemia: new insights into biology and therapy. , 1990, Annals of internal medicine.

[28]  W. Plunkett,et al.  Termination of DNA synthesis by 9-beta-D-arabinofuranosyl-2-fluoroadenine. A mechanism for cytotoxicity. , 1990, The Journal of biological chemistry.

[29]  Raymond L. Blakley,et al.  Incorporation of 2-halogeno-2'-deoxyadenosine 5-triphosphates into DNA during replication by human polymerases alpha and beta. , 1990, The Journal of biological chemistry.

[30]  Raymond L. Blakley,et al.  Mechanisms of inhibition of DNA synthesis by 2-chlorodeoxyadenosine in human lymphoblastic cells. , 1989, Cancer research.

[31]  M. Grever,et al.  Guidelines for clinical protocols for chronic lymphocytic leukemia: Recommendations of the national cancer institute‐sponsored working group , 1988, American journal of hematology.

[32]  A. Townsend,et al.  Interaction of 2-halogenated dATP analogs (F, Cl, and Br) with human DNA polymerases, DNA primase, and ribonucleotide reductase. , 1988, Molecular pharmacology.

[33]  D. Kufe,et al.  Incorporation of 9-beta-D-arabinofuranosyl-2-fluoroadenine into HL-60 cellular RNA and DNA. , 1986, Biochemical pharmacology.

[34]  R. Beabealashvilli,et al.  Sequence‐specific inhibition of RNA elongation by actinomycin D , 1983, FEBS letters.

[35]  L. T. Wright,et al.  Clinical evaluation of puromycin in human neoplastic disease. , 1955, A.M.A. archives of internal medicine.

[36]  P. Tassone,et al.  Triggering of CD40 antigen inhibits fludarabine-induced apoptosis in B chronic lymphocytic leukemia cells. , 1998, Blood.

[37]  C. Cazaux,et al.  Overexpression of DNA polymerase beta sensitizes mammalian cells to 2',3'-deoxycytidine and 3'-azido-3'-deoxythymidine. , 1997, Cancer research.

[38]  M. Talpaz,et al.  Fludarabine and granulocyte colony-stimulating factor (G-CSF) in patients with chronic lymphocytic leukemia , 1997, Leukemia.

[39]  J. Cherrington,et al.  Kinetic analysis of the interaction between the diphosphate of (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine, ddCTP, AZTTP, and FIAUTP with human DNA polymerases beta and gamma. , 1994, Biochemical pharmacology.

[40]  H. Kantarjian,et al.  Fludarabine phosphate: a new active agent in hematologic malignancies. , 1994, Seminars in hematology.

[41]  M. Story,et al.  Induction of apoptotic cell death in chronic lymphocytic leukemia by 2-chloro-2′-deoxyadenosine and 9-β-D-arabinosyl-2-fluoroadenine , 1993 .